A Nuclear Combination in Heterogeneous Metastatic Neuroendocrine Tumors
#1820
Introduction: Therapy with 177Lu-DOTATATE provides an objective response in neuroendocrine tumors (NET).
Aim(s): A clinical case of a metastatic NET with different grades of differentiation treated with PRRT and chemotherapy is presented.
Materials and methods: Clinical data were reviewed.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Sousa V, Timóteo T, Loewenthal C, Vieira R,
Keywords: PRRT,68Ga-DOTANOC,
To read the full abstract, please log into your ENETS Member account.